STOCK TITAN

Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)

Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in the Stifel 2025 Healthcare Conference in New York City on Wednesday, November 12, 2025.

A corporate presentation is scheduled for 4:40 p.m. Eastern Time and will be accessible live on Vanda's investor website via the Investors tab under Recent Events. Attendees are advised to arrive at the conference website at least 15 minutes early to register and download any required software or materials. Archived conference links will be available on Vanda's website for approximately 30 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-0.68% News Effect
-$2M Valuation Impact
$257M Market Cap
0.0x Rel. Volume

On the day this news was published, VNDA declined 0.68%, reflecting a mild negative market reaction. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $257M at that time.

Data tracked by StockTitan Argus on the day of publication.

WASHINGTON, Nov. 5, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Stifel 2025 Healthcare Conference in New York City on Wednesday, November 12, 2025. A corporate presentation is scheduled for 4:40 p.m. Eastern Time.

The corporate presentation given at the Stifel conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-stifel-2025-healthcare-conference-302606237.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda Pharmaceuticals (VNDA) present at the Stifel 2025 Healthcare Conference?

Vanda will present on Wednesday, November 12, 2025 at 4:40 p.m. Eastern Time.

How can investors watch the VNDA presentation live on November 12, 2025?

Watch live via Vanda's investor website by clicking the Investors tab and selecting Recent Events.

Will the VNDA Stifel 2025 presentation be available after the event and for how long?

Yes; archived links to the presentation will be posted on Vanda's website for about 30 days.

What should investors do before joining the VNDA live webcast at Stifel 2025?

Investors should go to the conference website at least 15 minutes early to register and download any required software or presentations.

Where on Vanda's site can I find the Stifel 2025 presentation for VNDA?

Go to vandapharma.com, select the Investors tab, then follow links under Recent Events to access the live or archived presentation.
Vanda Pharma

NASDAQ:VNDA

VNDA Rankings

VNDA Latest News

VNDA Latest SEC Filings

VNDA Stock Data

433.18M
54.85M
7.21%
78.54%
7.88%
Biotechnology
Pharmaceutical Preparations
Link
United States
WASHINGTON